EAM: 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide
EAM is a Ligand Of Interest in 5DFC designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5DFC_EAM_A_503 | 44% | 14% | 0.18 | 0.906 | 2 | 1.85 | 7 | 5 | 0 | 0 | 100% | 1 |
| 2YEK_EAM_B_1183 | 93% | 58% | 0.075 | 0.969 | 0.69 | 0.91 | 1 | 1 | 0 | 0 | 100% | 1 |
| 3P5O_EAM_A_1 | 90% | 48% | 0.075 | 0.958 | 0.9 | 1.11 | 1 | 3 | 1 | 0 | 100% | 1 |
